PRIMECAP Management Bolsters Stake in Biogen Inc

PRIMECAP Management (Trades, Portfolio) has recently increased its investment in Biogen Inc (NASDAQ:BIIB), a notable move that underscores the firm's confidence in the biotechnology company. The addition has adjusted PRIMECAP Management (Trades, Portfolio)'s position in Biogen Inc to 3.55% of its portfolio, representing an 11.22% stake in the company.

Related Keywords

United States , ,Biogen Inc Financial Health ,T Rowe Price Equity Income Fund ,Other Notable Investors In Biogen Inc ,Biogen Inc ,Overview Of Biogen Inc ,Vanguard Health Care Fund ,Gf Score Of Biogen Inc ,Financial Health ,Financial Strength ,Profitability Rank ,Drug Manufacturers ,Notable Investors ,Ken Fisher ,Joel Greenblatt ,Primecap Management ,Grades ,Portfolio ,Investment Philosophy ,Biotechnology Company ,